Dataset Information

A microRNA checkpoint for Ca²⁺ signaling and overload in acute pancreatitis.

ABSTRACT: Acute pancreatitis (AP) is a common digestive disease without specific treatment, and its pathogenesis features multiple deleterious amplification loops dependent on translation, triggered by cytosolic Ca²⁺ ([Ca²⁺]_i) overload; however, the underlying mechanisms in Ca²⁺ overload of AP remains incompletely understood. Here we show that microRNA-26a (miR-26a) inhibits pancreatic acinar cell (PAC) store-operated Ca²⁺ entry (SOCE) channel expression, Ca²⁺ overload, and AP. We find that major SOCE channels are post-transcriptionally induced in PACs during AP, whereas miR-26a expression is reduced in experimental and human AP and correlated with AP severity. Mechanistically, miR-26a simultaneously targets Trpc3 and Trpc6 SOCE channels and attenuates physiological oscillations and pathological elevations of [Ca²⁺]_i in PACs. MiR-26a deficiency increases SOCE channel expression and [Ca²⁺]_i overload, and significantly exacerbates AP. Conversely, global or PAC-specific overexpression of miR-26a in mice ameliorates pancreatic edema, neutrophil infiltration, acinar necrosis, and systemic inflammation, accompanied with remarkable improvements on pathological determinants related with [Ca²⁺]_i overload. Moreover, pancreatic or systemic administration of an miR-26a mimic to mice significantly alleviates experimental AP. These findings reveal a previously unknown mechanism underlying AP pathogenesis, establish a critical role for miR-26a in Ca²⁺ signaling in the exocrine pancreas, and identify a potential target for the treatment of AP.

SUBMITTER: Du W

PROVIDER: S-EPMC9077382 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

A microRNA checkpoint for Ca2+ signaling and overload in acute pancreatitis.

Du Wenya W Liu Geng G Shi Na N Tang Dongmei D Ferdek Pawel E PE Jakubowska Monika A MA Liu Shiyu S Zhu Xinyue X Zhang Jiayu J Yao Linbo L Sang Xiongbo X Zou Sailan S Liu Tingting T Mukherjee Rajarshi R Criddle David N DN Zheng Xiaofeng X Xia Qing Q Berggren Per-Olof PO Huang Wendong W Sutton Robert R Tian Yan Y Huang Wei W Fu Xianghui X

Molecular therapy : the journal of the American Society of Gene Therapy 20220122 4

Acute pancreatitis (AP) is a common digestive disease without specific treatment, and its pathogenesis features multiple deleterious amplification loops dependent on translation, triggered by cytosolic Ca2+ ([Ca2+]i) overload; however, the underlying mechanisms in Ca2+ overload of AP remains incompletely understood. Here we show that microRNA-26a (miR-26a) inhibits pancreatic acinar cell (PAC) store-operated Ca2+ entry (SOCE) channel express ...[more]

PMID: 35077860

Similar Datasets

Project description:Calcium overload, a notable instigator of acute pancreatitis (AP), induces oxidative stress and an inflammatory cascade, subsequently activating both endogenous and exogenous apoptotic pathways. However, there is currently lack of available pharmaceutical interventions to alleviate AP by addressing calcium overload. In the present study, the potential clinical application of liposome nanoparticles (LNs) loaded with 1,2‑bis(2‑aminophenoxy)ethane‑N,N,N',N'‑tetraacetic acid tetrakis (acetoxymethyl ester) (BAPTA‑AM), a cell‑permeant calcium chelator, was investigated as a therapeutic approach for the management of AP. To establish the experimental models in vitro, AR42J cells were exposed to high glucose/sodium oleate (HGO) to induce necrosis, and in vivo, intra‑ductal taurocholate (TC) infusion was used to induce AP. The findings of the present study indicated that the use of BAPTA‑AM‑loaded LN (BLN) effectively and rapidly eliminated excessive Ca2+ and reactive oxygen species, suppressed mononuclear macrophage activation and the release of inflammatory cytokines, and mitigated pancreatic acinar cell apoptosis and necrosis induced by HGO. Furthermore, the systemic administration of BLN demonstrated promising therapeutic potential in the rat model of AP. Notably, BLN significantly enhanced the survival rates of rats subjected to the TC challenge, increasing from 37.5 to 75%. This improvement was attributed to the restoration of pancreatic function, as indicated by improved blood biochemistry indices and alleviation of pancreatic lesions. The potential therapeutic efficacy of BLN in rescuing patients with AP is likely attributed to its capacity to inhibit oxidative stress, prevent premature activation of zymogens and downregulate the expression of TNF‑α, IL‑6 and cathepsin B. Thus, BLN demonstrated promising value as a novel therapeutic approach for promptly alleviating the burden of intracellular Ca2+ overload in patients with AP.

Dataset Information

A microRNA checkpoint for Ca²⁺ signaling and overload in acute pancreatitis.

Publications

A microRNA checkpoint for Ca<sup>2+</sup> signaling and overload in acute pancreatitis.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets